Phase Transitions in Frozen Systems and During Freeze–Drying: Quantification Using Synchrotron X-Ray Diffractometry
- 282 Downloads
(1) To develop a synchrotron X-ray diffraction (SXRD) method to monitor phase transitions during the entire freeze–drying cycle. Aqueous sodium phosphate buffered glycine solutions with initial glycine to buffer molar ratios of 1:3 (17:50 mM), 1:1 (50 mM) and 3:1 were utilized as model systems. (2) To investigate the effect of initial solute concentration on the crystallization of glycine and phosphate buffer salt during lyophilization.
Phosphate buffered glycine solutions were placed in a custom-designed sample cell for freeze–drying. The sample cell, covered with a stainless steel dome with a beryllium window, was placed on a stage capable of controlled cooling and vacuum drying. The samples were cooled to −50°C and annealed at −20°C. They underwent primary drying at −25°C under vacuum until ice sublimation was complete and secondary drying from 0 to 25°C. At different stages of the freeze–drying cycle, the samples were periodically exposed to synchrotron X-ray radiation. An image plate detector was used to obtain time-resolved two-dimensional SXRD patterns. The ice, β-glycine and DHPD phases were identified based on their unique X-ray peaks.
When the solutions were cooled and annealed, ice formation was followed by crystallization of disodium hydrogen phosphate dodecahydrate (DHPD). In the primary drying stage, a significant increase in DHPD crystallization followed by incomplete dehydration to amorphous disodium hydrogen phosphate was evident. Complete dehydration of DHPD occurred during secondary drying. Glycine crystallization was inhibited throughout freeze–drying when the initial buffer concentration (1:3 glycine to buffer) was higher than that of glycine.
A high-intensity X-ray diffraction method was developed to monitor the phase transitions during the entire freeze–drying cycle. The high sensitivity of SXRD allowed us to monitor all the crystalline phases simultaneously. While DHPD crystallizes in frozen solution, it dehydrates incompletely during primary drying and completely during secondary drying. The impact of initial solute concentration on the phase composition during the entire freeze–drying cycle was quantified.
Key wordsdisodium hydrogen phosphate dodecahydrate glycine in situ freeze–drying phase transitions phosphate buffer synchrotron X-ray diffraction
- 1.M. J. Pikal. Freeze Drying. In J. Swarbrickand, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, , New York, 2002, pp. 1299–1326.Google Scholar
- 4.L. A. Trissel. Handbook of injectable drugs. ASHP, Bethesda, MD, 1994.Google Scholar
- 9.E. Y. Shalaev. The impact of buffer on processing and stability of freeze–dried dosage forms, part 1: solution freezing behavior. Am. Pharm. Rev. 8:80–87 (2005).Google Scholar
- 15.G. Gomez. Crystallization related pH changes during freezing of sodium phosphate buffer solutions. Ph.D. dissertation, Department of Pharmaceutics, University of Michigan, Ann Arbor, 1995, p. 188.Google Scholar
- 33.Powder Diffraction File. hexagonal ice, card#00-042-1142; disodium hydrogen phosphate dodecahydrate, card#00-011-0657; α-glycine, card#00-032-1702; β-glycine, card#00-002-0171; γ-glycine, card#00-006-0230 International Centre for Diffraction Data, Newtown Square, PA (1996).Google Scholar
- 34.A. Pyne, K. Chatterjee, and R. Suryanarayanan. Crystalline to amorphous transition of disodium hydrogen phosphate during primary drying. J. Pharm. Sci. 20:802–803 (2003).Google Scholar
- 36.I. Weissbuch, V. Y. Torbeev, L. Leiserowitz, and M. Lahav. Solvent effect on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable β form of glycine. Angew. Chem. 44:3226–3229 (2005). doi:10.1002/anie.200500164.CrossRefGoogle Scholar
- 37.E. Y. Shalaev, D. V. Malakhov, A. N. Kanev, V. I. Kosyakov, F. V. Tuzikov, N. A. Varaksin, and V.I. Vavilin. Study of the phase diagram water fraction of the system water-glycine-sucrose by DTA and X-ray diffraction methods. Thermochim. Acta. 196:213–220 (1992). doi:10.1016/0040-6031(92)85021-M.CrossRefGoogle Scholar
- 41.C. Nunes. Use of high-intensity X-radiation in solid-state characterization of pharmaceuticals. Ph.D. dissertation, Department of Pharmaceutics, University of Minnesota, Minneapolis, 2005, p. 197.Google Scholar
- 44.A. P. Hammersley. ESRF internal report, ESRF97HA02T. “Fit2D: an introduction and overview”. (1997).Google Scholar